Mar 31, 2025
Your Directors have pleasure in presenting the 32nd Annual Report of your Company along with the Audited Financial Statement for the year ended March 31, 2025.
1. SUMMARY OF FINANCIAL RESULTS:
Following is the analysis of the standalone financial statements of the Company during the year under review:
|
(Rupees in Lacs |
||
|
Particulars |
For the financial year ended 31st March, 2025 (Rs.) |
For the financial year ended 31st March, 2024 (Rs.) |
|
Revenue from Operation including other income |
6435.61 |
2366.11 |
|
Expenses excluding Depreciation |
5215.54 |
2254.50 |
|
Depreciation and Amortization |
22.31 |
2.95 |
|
Profit (Loss) Before Tax |
1197.75 |
108.66 |
|
Extraordinary items |
0.00 |
0.00 |
|
Current Tax |
294.08 |
29.37 |
|
Deferred Tax Adjustment |
11.14 |
0.82 |
|
Profit (loss) After Tax |
892.53 |
78.47 |
|
Net fixed assets |
1144.43 |
69.00 |
|
Share capital |
984.56 |
984.56 |
|
Reserve & Surplus Profit/(Loss) |
2614.91 |
1349.60 |
The financial year 2024-25 was a year of satisfactory performance by the Company and the Second year in venturing into pharmaceutical bulk and Intermediates business.
During the year, the revenue from operations increased from Rs. 2364.77/ - Lacs to Rs. 6423.10/-Lacs, recorded a growth of 171.64% in comparison to the revenue from previous financial year. Profit after Tax (PAT) recorded increase of 1039.20% from Rs. 78.47 Lacs to 892.53 Lacs due to commencement of Bulk drug business by the company.
The Astal Laboratories Limited (formerly Macro International Limited) have done considerable progress in the company in terms of Business, Investments, Net worth and market capitalization. The company''s focuses totally on to production of Pharmaceutical Bulk Drugs (Active Pharma Ingredients) and Key Starting Materials / Intermediates.
Highlights of Company''s performance is covered in detail in the Management Discussion and Analysis Report (MDA), included in this Annual Report as required under Schedule V of the SEBI (LODR) Regulations, 2015.
The Board of Directors not recommend any Dividend for the F.Y 2024-25 and decides use the surplus in the P&L account for increased working capital needs.
Section 124 of the Companies Act, 2013 read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 (the Rules) provides that the dividend that has remained unclaimed or unpaid for a period of seven years is to be transferred to Investor Education and Protection Fund (IEPF). Further, the Rules mandate that the shares on which dividend has not been paid or claimed for seven consecutive years or more shall also be transferred to the IEPF.
In your company there is no outstanding dividend. During the year under review and the Company has not transferred any amount to the IEPF account as per the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
The Company does not propose to transfer any amount to general reserves.
6. CHANGE IN THE NATURE OF BUSINESS, IF ANY
There has been no change in the line or nature of business that the Company is operating in during the year under review.
7. INFORMATION ABOUT SUBSIDIARY/ ASSOCIATE COMPANY:
During the year under review, the Company does not have any Subsidiaries, Joint Venture or Associate Companies.
Company has not accepted any deposits from the public, during the year under review.
9. INDIAN ACCOUNTING STANDARDS:
The annexed financial statements for the Financial Year 2024-25 and corresponding figures for 2023-24 comply in all material aspects with the Indian Accounting Standards notified under section 133 of the Companies Act, 2013 (the Act), the Companies (Indian Accounting Standards) Rules, 2015 and other relevant provisions of the Act as modified from time to time.
10. MATERIAL CHANGES AND COMMITMENTS:
As on the date of this report, there are no material changes and commitments affecting the financial position of the company have occurred.
Annual Return as required under Section 92(3) of the Companies Act, 2013 and rule 12(1) of the Companies (Management and Administration) Rules, 2014, is available on website of the company and can be accessed at https:/ / astallabs.com/
12. DIRECTORS''_RESPONSIBILITYSTATEMENT:
Pursuant to clause (c) of sub-section (3) of Section 134 of the Companies Act, 2013 with respect to Directors'' Responsibility Statement it is confirmed that-
a. In the preparation of the annual accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures;
b. Such accounting policies have been selected and applied consistently and judgments and estimates have been made that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of the financial year 2024-25 and of the profit of the company for that period;
c. Proper and sufficient care has been taken for the maintenance of adequate accounting records in accordance with the provisions of Companies Act for safeguarding the assets of the company and for preventing and detecting fraud and other irregularities;
d. The annual accounts have been prepared on a going concern basis.
e. That internal financial control were laid down to be followed and that such internal financial controls were adequate and were operating effectively.
f. That proper system was devised to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.
The Authorised share Capital of the Company is Rs. 20,00,00,000.00/- Divided into 20,000,000 equity shares of Rs. 10 each and the Paid-up share capital of the company is Rs. 9,83,00,700.00/-divided into 98,30,070 Shares of Rs. 10 each.
During the year under review the Company has allotted through preferential allotment basis
37,29,930 warrants convertible in equal number of equity shares upon exercise the option to conversion within eighteen months.
The Company has only one class of Equity Share having a par value of Rs. 10/-each holder of share is entitled to one vote per share with same rights.
During the Year 2024-25, the company has not made any issue of equity shares with differential voting rights, Sweat Equity Shares and employee stock option.
Shares of company have been listed on Bombay Stock Exchange.
15. AUDITORS:a. STATUTORY AUDITORS:
Pursuant to the provisions of Section 139 of the Companies Act, 2013 and the rules made thereunder, M/s Sathuluri & Co., Chartered Accountants (Firm Registration No. 006383S), were appointed as Statutory Auditors of the Company for a further term of 5 (Five) years to hold office from the conclusion of 29th Annual General Meeting of the Company held on 30th September, 2022 until the conclusion of the 34th Annual General Meeting to be held for the financial year 2026-27.
The Report given by M/s. Sathuluri & Co., Chartered Accountants (Firm Registration No. 006383S), Statutory Auditors on the financial statement of the Company for the year 2024-2025 is part of the Annual Report. There is no qualification, reservation or adverse remark or disclaimer in their Report.
During the year under review, the Statutory Auditors had not reported any matter under Section 143 (12) of the Act, therefore no detail is required to be disclosed to the Boards Report.
The Report of the Statutory Auditors on the financial statements including relevant notes on the accounts for the Financial Year ended 31st
March, 2025 are self-explanatory and therefore do not call for any further comments.
The Board has appointed M/s Mahendra Prakash Khandelwal & Co., Practicing Company Secretaries, Jaipur as Secretarial Auditor pursuant to the provisions of Section 204 of the Companies Act, 2013 for the financial year 20242025. The Report of the Secretarial Auditor is annexed to the Report as per "Annexure I".
EXPLANATION IN RESPONSE TO AUDITOR''S QUALIFICATIONS
There were no qualifications, reservations or adverse remarks made by the Statutory Auditors in their report.
There were no qualifications, reservations or adverse remarks made by the Secretarial Auditor in their Secretarial Audit Report.
Further, pursuant to recent amendments in the Regulation 24A of SEBI LODR Regulations, the Company is required to appoint a Secretarial Auditor for a term of five consecutive years.
The Company has received consent from M/s Mahendra Khandelwal & Co., a peer Reviewed Company Secretary firm to act as the Secretarial Auditor of the Company from the FY 2025-26 to 2029-30, along with the certificate confirming his eligibility.
The Board of Directors on the recommendation of the Audit Committee Meeting held on May 19, 2025, subject to the approval of the members, appointed M/s Mahendra Khandelwal & Co., Company Secretaries as the Secretarial Auditor of the Company for a period of five years from FY 2025-26 to FY 2029-30.
Accordingly, the board recommends to the members appointment of M/s Mahendra Khandelwal & Co., as the Secretarial Auditors of
the Company for a term of five consecutive years. A resolution seeking approval of appointment of secretarial auditor forms part of the Notice convening the ensuing Annual General Meeting.
16. COMPLIANCE WITH SECRETARIAL STANDARDS ON BOARD AND ANNUAL GENERAL MEETINGS
The Company has complied with Secretarial Standards issued by the Institute of Company Secretaries of India on Board Meetings and Annual General Meetings.
RESOLUTION PROCESS INITIATED UNDER THE INSOLVENCY AND BANKRUPTCY CODE, 2016 (IBC)
There is no proceeding pending under the Insolvency and Bankruptcy Code, 2016 during the period under review.
18. DIRECTORS /KEY MANAGERIAL PERSONNEL:a. Independent Directors and their Declaration of Independence
The Board of the Company as on March 31, 2025 consisted of 7 directors out of which 4 are independent directors.
All Independent Directors have given declaration that they meet the criteria of independence as laid down under Section 149(6) of the Companies Act, 2013 and Regulation 16 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
a. Composition of Board of Director as on 31st March 2025 and changes during the year
The Board of the Company as on March 31, 2025 consists of 7 directors out of which 4 are independent directors, one is Whole Time Director and two are non-Executive directors.
b. Re-Appointment of Directors Retiring by Rotation:
The Independent Directors and Whole-Time Director hold office for a fixed period of five years from the date of their appointment and are not liable to retire by rotation. Out of the remaining Non-Executive/ Non-Independent Directors, in accordance with the provisions of the Companies Act and the Articles of Association of the Company, Mrs. Ravikanti Shailaja (DIN: 07629653) is liable to retire by rotation and being eligible, offer his candidature for reappointment as Director.
Changes in Composition of the Board of Directors During the year under review
Mr. Birendrakumar Sahoo (DIN: 06737993) was appointed as Non-Executive Independent Director of the company w.e.f. 24/05/2024.
Dr. Julius Paul Reinhard Paschke (DIN: 10819043) was appointed as Non-Executive Independent Director of the company w.e.f. 21/12/2024.
c. Changes in Composition of the Board of Directors after the end of Financial Year: NIL
Key Managerial Personnel Changes in the composition of Key Managerial Personnel (other than Board of Directors): NIL
19. COMMITTEE DETAILS Audit Committee
The Audit Committee comprises of Independent Directors namely Shri Radhakishore Pandrangi (DIN: 06664969) (Independent Director and Chairman), Smt. Hemachakrapani
Bangaraiahgari (Independent Director) and Smt. Ravikanti Shailaja (Non-Executive NonIndependent Director) as other Members. All the recommendations made by the Audit Committee were accepted by the Board.
Nomination and Remuneration Committee
The Nomination and Remuneration Committee comprises of Mr. Radhakishore Pandrangi (Independent Director) (Chairman), Smt. Hemachakrapani Bangaraiahgari (Independent Director) and Smt. Ravikanti Shailaja (NonExecutive Non Independent Director) as other Member.
All the recommendations made by the Nomination and Remuneration Committee were accepted by the Board.
Stakeholders'' Relationship Committee
The Stakeholders Relationship Committee comprises of Shri Radhakishore Pandrangi (Independent Director) (Chairman) Smt. Ravikanti Shailaja (Non-Executive NonIndependent Director) and Smt. Hemachakrapani Bangaraiahgari (Independent Director) as other Member.
All the recommendations made by the Nomination and Remuneration Committee were accepted by the Board.
Corporate Social Responsibility Committee
The Corporate Social Responsibility Committee comprises of Mr. Mr. Sudheer Karna Kankanala (Chairman) and Mrs. Ravikanti Shailaja and Mr. Birendrakumar Sahoo as members of the Committee.
20. VIGIL MECHANISM
The Vigil Mechanism of the Company, which also incorporates a Whistle Blower Policy in terms of the Listing Regulations with the Stock Exchange. It aims to provide an avenue for employees through this policy to raise their concerns on any violation of legal or regulatory requirements, suspicious fraud, misfeasance.
misrepresentation of any Financial Statements and Reports.
21. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO
The details of conservation of energy, technology absorption, foreign exchange earnings and outgo are as follows:
a. Conservation of energy:
The operations of the Company involve low energy consumption. The Company has ensured that adequate measures are being taken to conserve energy.
b. Technology Absorption:
The particulars regarding Technology absorption are: NIL
c. Foreign exchange earnings and Outgo:
|
Particulars |
As on 31.03.2025 |
As on 31.03.2024 |
|
a) Earnings in foreign exchange |
Nil |
Nil |
|
b) Expenditure / outgo in foreign exchange (Travelling) |
25.54 |
Nil |
22. MEETINGS
During the financial year 2024-25, following meetings were convened:
? Board Meetings
|
S. No. |
Date of Board Meeting |
Board''s Strength |
No. of Directors Present |
||
|
1. |
24/05/2024 |
5 |
5 |
||
|
2. |
06/07/2024 |
6 |
6 |
||
|
3. |
27/07/2024 |
6 |
6 |
||
|
4. |
12/11/2024 |
6 |
6 |
||
|
5. |
27/11/2024 |
6 |
6 |
||
|
6. |
27/01/2025 |
7 |
6 |
||
|
? Audit Committee Meetings |
|||||
|
S. No. |
Date of Meeting |
Strength of Members |
No. of Members Present |
||
|
1. |
24/05/2024 |
3 |
3 |
||
|
2. |
27/07/2024 |
3 |
3 |
||
|
3. |
12/11/2024 |
3 |
3 |
||
|
4. |
27/01/2025 |
3 |
3 |
||
|
? Nomination & Remuneration Committee Meetings |
|||||
|
S. No. |
Date of Meeting |
Strength of Member s |
No. of member s present |
||
|
1. |
17/05/2024 |
3 |
3 |
||
|
2. |
22/06/2024 |
3 |
3 |
||
|
3. |
05/11/2024 |
3 |
3 |
||
|
? Independent Director''s Meeting |
|||||
|
S. No. |
Date of Meeting |
Strength of Member s |
No. of member s present |
||
|
1. |
27/01/2025 |
4 |
3 |
||
|
? Stakeholder Relationship''s Committee Meeting |
||||||||
|
S. No. |
Date of Meeting |
Strength of Member s |
No. of member s present |
|||||
|
1. |
24/05/2024 |
3 |
3 |
|||||
|
2. |
06/07/2024 |
3 |
3 |
|||||
|
3 |
01/02/2025 |
3 |
3 |
|||||
|
4. |
12/03/2025 |
3 |
3 |
|||||
|
? Members Meeting |
||||||||
|
S. No. |
Type of Meeting |
Date of Meetin g |
Total No. of Membe rs Entitle to Attend |
Num ber of Mem bers Atten ded |
||||
|
1. |
Annual General Meeting |
05-08 2024 |
1415 |
29 |
||||
|
? Postal Ballot |
||||||||
|
S. No. |
Type of Meetin g |
Record date |
Total No. of Members Entitle to Vote |
|||||
|
1. |
Postal Ballot |
15-11-2024 |
1875 |
|||||
23. PERFORMANCE EVALUATION OF THE BOARD, COMMITTEES AND INDIVIDUAL DIRECTORS
The Company has formulated a Board Evaluation template for performance evaluation of the Independent Directors, the Board, its Committees and other individual Directors which includes criteria for performance evaluation of the Non-Executive Directors and Executive Directors.
The formal Board evaluation as mandated under the Companies Act and Listing Regulations has been carried out during the year.
24. SETTLEMENT WITH BANK OR FINANCIAL INSTITUTION:
There was no instance of one-time settlement with any Bank or Financial Institution.
25. DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN ATWORKPLACE_(PREVENTION,PROHIBITION AND REDRESSAL) ACT, 2013
The Company has in place an appropriate Policy on Prevention of Sexual Harassment of Women at Workplace in accordance with the provisions of The Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013, to prevent sexual harassment of its employees.
During the year under review,
(a) Number of complaints of sexual harassment received: NIL
(b) Number of complaints disposed: NA
(c) Number of cases pending for more than ninety days: NA
During the period under review, The Company has complied with the provisions relating to the Maternity Benefit Act, 1961
27. DETAILS OF ESTABLISHMENT OF VIGIL MECHANISM FOR DIRECTORS AND EMPLOYEES:
The company has established a vigil mechanism for grievances redressal of director and employees of the company which will help in reporting genuine concerns or grievances of directors and employees.
28. CORPORATE SOCIAL RESPONSIBILITY (CSR):
The Corporate Social Responsibility Policy, as formulated by the Corporate Social Responsibility Committee and approved by the Board of Directors is available on the Company''s website at https:/ /astallabs.com/ .
During the year under review the Company was not falling under the class of companies as prescribed under Section 135 of Companies Act, 2013 and Rules made there under, therefore the provisions related to Corporate Social Responsibility were not applicable on the Company.
29. PARTICULARS_OF_LOANS,
GUARANTEES OR INVESTMENTS UNDER SECTION 186:
Particulars of Loan given, Investments made, guarantees given and securities provided along with the purpose for which the loan or guarantee or security is proposed to be utilized by the recipient are provided in standalone financial statement.
30. PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES:
Related party transactions, if any, pursuant to the SEBI LODR Regulations, were approved by the Audit Committee from time to time prior to entering into the transactions. The related party transactions undertaken during financial year 2024-25 are detailed in the Notes to Accounts of the Financial Statements. The particulars of contracts or arrangements entered into by the Company with related parties referred to in subsection (1) of Section 188 of the Companies Act, 2013 including certain arm''s length transactions under the proviso thereto have been disclosed in Form No. AOC -2, as Annexure -II.
31. MANAGERIAL REMUNERATION:
The statement containing particulars in terms of Sectionv197(12) of the Companies Act, 2013 read with Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 forms part of this report and is appended herewith as Annexure III to the Board''s Report.
32. INFORMATION PURSUANT TO RULE-5 OF THE COMPANIES (APPOINTMENT
AND_REMUNERATION)_OF
MANAGERIAL PERSON, RULE, 2014 OF THE COMPANIES ACT, 2013:
None of the employee is in receipt of remuneration in excess of the limits prescribed under Rule 5(2) of Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 i.e. The company has not employed any employee for any post that has paid remuneration in excess of Rs. 1,02,00,000/- per annum or in excess of Rs. 8,50,000/- per month.
33. NOMINATION AND REMUNERATION POLICY
The Nomination & Remuneration Committee of the Board of Directors is responsible for recommending the appointment of the Directors and senior management to the Board of Directors of the Company. The Company has in place a Nomination and Remuneration Policy containing the criteria for determining qualifications, positive attributes and independence of a Director and policy relating to the remuneration for the Directors, Key Managerial Personnel and senior management personnel of the Company. The committee also postulates the methodology for effective evaluation of the performance of Individual Directors, committees of the Board and the Board as a whole which should be carried out by the Board, committee or by an independent external agency and review its implementation and compliance. The Nomination and Remuneration Policy is attached as Annexure IV and is also available on the Company''s website at https://astallabs.com/ .
34. RISK MANAGEMENT POLICY:
The Company has its Risk Management Policy to identify and deal with the risks and threats that could impact the organization. Risk Management Policy is available for inspection at the Registered Office of the Company during business hours on any working day.
35. DETAILS IN RESPECT OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS WITH REFERENCE TO THE FINANCIALS STATEMENTS:
The Company has proper place and adequate internal control systems commensurate with the nature of its business, and size and complexity of its operations. Internal control systems comprising of policies and procedures are designed to ensure reliability of financial reporting, timely feedback on achievement of operational and strategic goals, compliance with policies, procedure, applicable laws and regulations, and all assets and resources are acquired economically, used efficiently and adequately protected.
36. DETAILS OF SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALS IMPACTING THE GOING CONCERN STATUS AND COMPANY''S OPERATIONS IN FUTURE:
There were no orders passed by the regulators or courts or tribunals impacting the going concern status and company''s operations in future.
37. OTHER DISCLOSURES AND STATUTORY INFORMATION:a. Policies and code adopted by the Company
The Board of Directors has from time to time framed and approved policies as required by the SEBI LODR Regulations as well as under the Companies Act, 2013. These policies will be
reviewed by the Board at periodic intervals. Some of the key policies that have been adopted are as follows
? Code for Disclosure of Unpublished Price Sensitive Information
? Code of Conduct for Insider Trading
? Policy on Related Party Transactions
? Code of Conduct for Directors and Senior Management Personnel
? Whistle Blower Policy
38. HUMAN RESOURCES MANAGEMENT
We firmly believe that employee motivation, development and engagement are key aspect of good human resource management. We provide several forums and communication channels for our employees to not only share their point of view and feedback related to our business, but also share feedback self-development and career advancement. These forums have helped us to identify and implement a number of structural changes during the year under review.
An acknowledgement with thanks is hereby conveyed to all with whose help, cooperation and hard work the Company was able to achieve the results.
Mar 31, 2024
Your Directors have pleasure in presenting the 31st Annual Report of your Company along with the Audited Financial Statement for the year ended March 31, 2024.
Following is the analysis of the standalone financial statements of the Company during the year under review:
|
Particulars |
For the financial year ended 31st March, 2024 (Rs.) |
For the financial year ended 31st March, 2023 (Rs.) |
|
Revenue from Operation including other income |
2366.11 |
360.68 |
|
Expenses excluding Depreciation |
2254.50 |
356.68 |
|
Depreciation and Amortization |
2.95 |
0.79 |
|
Profit (Loss) Before Tax |
108.66 |
3.21 |
|
Extraordinary items |
0.00 |
0.00 |
|
Current Tax |
29.37 |
0.96 |
|
Deferred Tax Adjustment |
0.82 |
0.60 |
|
Profit (loss) After Tax |
78.47 |
1.64 |
|
Net fixed assets |
69.00 |
0.56 |
|
Share capital |
984.56 |
398.96 |
|
Reserve & Surplus Profit/(Loss) |
1349.60 |
118.71 |
The financial year 2023-24 was a year of satisfactory performance by the Company and the FIRST YEAR in venturing into pharmaceutical bulk and Intermediates business.
During the year, the revenue from operations increased from Rs. 342.81/- Lacs to Rs. 2364.77/- Lacs, recorded a growth of 589.82 % in comparison to the revenue from previous financial year. Profit after Tax (PAT) recorded increase of 4670.76% from Rs. 1.64 Lacs to 78.47 Lacs due to commencement of Bulk drug business by the company.
As you are aware the management of the company had changed with new promoters in financial year 2022 -23 by takeover of the company through open offer. From the date of Open offer till date the new management and Board of Astal Laboratories Limited (formerly Macro International Limited) have done considerable progress in the company in terms of Business, Investments, Net worth and market capitalization. The company''s focuses totally on to production of Pharmaceutical Bulk Drugs (Active Pharma Ingredients) and Key Starting Materials / Intermediates.
As you are aware that the projected size of the Indian API market stands at over US$ 13.5 billion in 2024, with an expected growth of over US$ 20 billion by 2029. This represents a compound annual growth rate of 8.3% over the forecast 5-year period. The increasing prevalence of infectious diseases, genetic disorders, and chronic conditions are envisaged as a primary catalyst to drive market expansion.
Now this has underscored the importance of intensifying efforts towards the development of advanced pharmaceuticals necessitating a significant volume of APIs. Additional growth drivers seen are the expanding elderly demographic and the increased domestic manufacture of generic drugs.
Highlights of Company''s performance is covered in detail in the Management Discussion and Analysis Report (MDA), included in this Annual Report as required under Schedule V of the SEBI (LODR) Regulations, 2015.
The Board of Directors not recommend any Dividend for the F.Y 2023-24 and decides use the surplus in the P&L account for increased working capital needs.
Section 124 of the Companies Act, 2013 read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 (the Rules) provides that the dividend that has remained unclaimed or unpaid for a period of seven years is to be transferred to Investor Education and Protection Fund (IEPF). Further, the Rules mandate that the shares on which dividend has not been paid or claimed for seven consecutive years or more shall also be transferred to the IEPF.
In your company there is no outstanding dividend. During the year under review and the Company has not transferred any amount to the IEPF account as per the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
The Company does not propose to transfer any amount to general reserves.
There has been no change in the line or nature of business that the Company is operating in during the year under review. In financial year 2022-2023 the Company entered in the business of Pharmaceutical Bulk Drugs (Active Pharma Ingredients) and Key Starting Materials / Intermediates.
During the year under review, the Company does not have any Subsidiaries, Joint Venture or Associate Companies.
Company has not accepted any deposits from the public, during the year under review.
The annexed financial statements for the Financial Year 2023-24 and corresponding figures for 2022-23 comply in all material aspects with the Indian Accounting Standards notified under section 133 of the Companies Act, 2013 (the Act), the Companies (Indian Accounting Standards) Rules, 2015 and other relevant provisions of the Act as modified from time to time.
As on the date of this report, there are no material changes and commitments affecting the financial position of the company have occurred.
Annual Return as required under Section 92(3) of the Companies Act, 2013 and rule 12(1) of the Companies (Management and Administration) Rules, 2014, is available on website of the company and can be accessed at https://meil.co.in.
Pursuant to clause (c) of sub-section (3) of Section 134 of the Companies Act, 2013 with respect to Directors'' Responsibility Statement it is confirmed that-
a. In the preparation of the annual accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures;
b. Such accounting policies have been selected and applied consistently and judgments and estimates have been made that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of the financial year and of the loss of the company for that period;
c. Proper and sufficient care has been taken for the maintenance of adequate accounting records in accordance with the provisions of Companies Act for safeguarding the assets of the company and for preventing and detecting fraud and other irregularities;
d. The annual accounts have been prepared on a going concern basis.
e. That internal financial control were laid down to be followed and that such internal financial controls were adequate and were operating effectively.
f. That proper system was devised to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.
13. SHARE CAPITAL:
The Authorised share Capital of the Company is Rs. 20,00,00,000.00/- Divided into 20,000,000 equity shares of Rs. 10 each and the Paid-up share capital of the company is Rs. 9,83,00,700.00/-divided into 98,30,070 Shares of Rs. 10 each. During the year under review, the Company has increased the Authorised share Capital of the Company from Rs. 50,000,000.00/- divided into
50.00. 000 equity shares of Rs. 10 each to Rs.
20.00. 00.000.00/- Divided into 20,000,000 equity shares of Rs. 10 each and the Company has issued 58,56,000 equity shares (9,50,000 Equity Shares of Face Value of Rs. 10/- (Rupee Ten only) each at a premium of Rs.18/- each and 4906000 (Forty-nine Lakh Six Thousand) Equity Shares of Face Value of Rs. 10/- each at premium of Rs.20/- each) to the non-promoters through preferential allotment basis.
The Company has only one class of Equity Share having a par value of Rs. 10/-each holder of share is entitled to one vote per share with same rights.
During the Year 2023-24, the company has not made any issue of equity shares with differential voting rights, Sweat Equity Shares and employee stock option.
Shares of company have been listed on Bombay Stock Exchange.
Pursuant to the provisions of Section 139 of the Companies Act, 2013 and the rules made thereunder, M/ s Sathuluri & Co., Chartered Accountants (Firm Registration No. 006383S), were appointed as Statutory Auditors of the Company for a further term of 5 (Five) years to hold office from the conclusion of 29th Annual General Meeting of the Company held on 30th September, 2022 until the conclusion of the 34th Annual General Meeting to be held for the financial year 2026-27.
The Report given by M/s. Sathuluri & Co., Chartered Accountants (Firm Registration No. 006383S), Statutory Auditors on the financial statement of the Company for the year 2023-2024 is part of the Annual Report. There is no qualification, reservation or adverse remark or disclaimer in their Report.
During the year under review, the Statutory Auditors had not reported any matter under Section 143 (12) of the Act, therefore no detail is required to be disclosed to the Boards Report.
The Report of the Statutory Auditors on the financial statements including relevant notes on the accounts for the Financial Year ended 31st March, 2024 are self-explanatory and therefore do not call for any further comments.
The Board has appointed M/s Mahendra Prakash Khandelwal & Co., Practicing Company Secretaries, Jaipur as Secretarial Auditor pursuant to the provisions of Section 204 of the Companies Act, 2013 for the financial year 20232024. The Report of the Secretarial Auditor is annexed to the Report as per "Annexure I".
There were no qualifications, reservations or adverse remarks made by the Statutory Auditors in their report.
There were no qualifications, reservations or adverse remarks made by the Secretarial Auditor in their Secretarial Audit Report.
16. COMPLIANCE WITH SECRETARIAL STANDARDS ON BOARD AND ANNUAL GENERAL MEETINGS
The Company has complied with Secretarial Standards issued by the Institute of Company Secretaries of India on Board Meetings and Annual General Meetings.
RESOLUTION PROCESS INITIATED UNDER THE INSOLVENCY AND BANKRUPTCY CODE, 2016 (IBC)
There is no proceeding pending under the Insolvency and Bankruptcy Code, 2016 during the period under review.
The Board of the Company as on March 31, 2024 consisted of 5 directors out of which 2 are independent directors.
All Independent Directors have given declaration that they meet the criteria of independence as laid down under Section 149(6) of the Companies Act, 2013 and Regulation 16 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
a. Composition of Board of Director as on 31st March 2024 and changes during the year
The Board of the Company as on March 31, 2024 consists of 5 directors out of which 2 are independent directors, one is Whole Time Director and two are non-Executive directors.
b. Re-Appointment of Directors Retiring by Rotation:
The Independent Directors and Whole-Time Director hold office for a fixed period of five years from the date of their appointment and are not liable to retire by rotation. Out of the remaining Non-Executive/ NonIndependent Directors, in accordance with the provisions of the Companies Act and the Articles of Association of the Company, Mr. MAGGIDI VENKATESH (DIN: 09414495) is liable to retire by rotation and being eligible, offer his candidature for reappointment as Director.
During the year under review
Mr. Birendrakumar Sahoo (DIN: 06737993) resigned from the designation of NonExecutive Independent Director of the company w.e.f. 19/06/2023.
Mr. MAGGIDI VENKATESH (DIN: 06737993) was appointed as Non-Executive Director of the company w.e.f. 10/06/2023.
Mr. Lakshmi Narasimha Anand Kumar Kanuparthi (DIN: 08926738) was appointed as Additional Non- Executive Director of the company w.e.f. 10/06/2023.
Mr. Lakshmi Narasimha Anand Kumar Kanuparthi (DIN: 08926738) resigned from the designation of Additional Non -Executive Director of the company w.e.f. 15/07/2023.
Mr. Radhakishore Pandrangi (DIN: 06664969) was appointed as Non-Executive Independent Director of the company w.e.f. 18/08/2023.
c. Changes in Composition of the Board of Directors after the end of Financial Year:
Mr. Birendrakumar Sahoo (DIN: 06737993) Appointed as Non-Executive Independent Director of the company w.e.f. 24/06/2024.
Key Managerial Personnel Changes in the composition of Key Managerial Personnel (other than Board of Directors):
Mr. Mahendra Kumar was appointed as the Company Secretary & Compliance Officer of the company w.e.f. 19/04/2023.
Mr. Chintalapati Sesha Sai Nikhil was appointed as the Chief Financial Officer (CFO) of the Company w.e.f. 27/05/2023.
Mr. Kommera Harish resigned from the designation of Chief Executive Officer (CEO) of the Company w.e.f. 19/06/2023.
Mr. Chintalapati Sesha Sai Nikhil resigned from the designation of Chief Financial Officer (CFO) of the Company w.e.f. 19/06/2023.
Mr. Balayogiswara Rao Peddinti was appointed as the Chief Financial Officer (CFO) of the Company w.e.f. 15/07/2023.
19. COMMITTEE DETAILS
Audit Committee
The Audit Committee comprises of Independent Directors namely Shri Radhakishore Pandrangi (DIN: 06664969) (Independent Director and Chairman), Smt. Hemachakrapani
Bangaraiahgari (Independent Director) and Smt. Ravikanti Shailaja (Non-Executive NonIndependent Director) as other Members.
The operations of the Company involve low energy consumption. The Company has ensured that adequate measures are being taken to conserve energy.
b. Technology Absorption:
The particulars regarding Technology absorption are: NIL
c. Foreign exchange earnings and Outgo:
|
Particulars |
As on |
As on |
|
31.03.2024 |
31.03.2023 |
|
|
a) Earnings in foreign exchange |
Nil |
Nil |
|
b) Expenditure / outgo in foreign exchange (Travelling) |
Nil |
Nil |
The Nomination and Remuneration Committee comprises of Smt. Ravikanti Shailaja (Chairman), Radhakishore Pandrangi (Independent Director) and Smt. Hemachakrapani Bangaraiahgari
(Independent Director) as other Member.
All the recommendations made by the Nomination and Remuneration Committee were accepted by the Board.
The Stakeholders Relationship Committee comprises of Smt. Ravikanti Shailaja (Chairman), Shri Radhakishore Pandrangi (Independent Director) and Smt. Hemachakrapani Bangaraiahgari
(Independent Director) as other Member.
All the recommendations made by the Nomination and Remuneration Committee were accepted by the Board.
The Vigil Mechanism of the Company, which also incorporates a Whistle Blower Policy in terms of the Listing Regulations with the Stock Exchange. It aims to provide an avenue for employees through this policy to raise their concerns on any violation of legal or regulatory requirements, suspicious fraud, misfeasance. misrepresentation of any Financial Statements and Reports.
21. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO
The details of conservation of energy, technology absorption, foreign exchange earnings and outgo are as follows:
During the financial year 2023-24, following meetings were convened:
|
S. |
Date of |
Board''s |
No. of |
|
No. |
Board |
Strength |
Directors |
|
Meeting |
Present |
||
|
1. |
19/04/2023 |
4 |
4 |
|
2. |
27/05/2023 |
4 |
4 |
|
3. |
10/06/2023 |
4 |
4 |
|
4. |
15/07/2023 |
4 |
4 |
|
5. |
18/08/2023 |
4 |
4 |
|
6. |
13/10/2023 |
5 |
5 |
|
7. |
10/11/2023 |
5 |
5 |
|
8. |
08/12/2024 |
5 |
5 |
|
9. |
20/12/2023 |
5 |
5 |
|
10. |
09/02/2023 |
5 |
5 |
|
S. No. |
Date of Meeting |
Strength of Member s |
No. of Member s Present |
|
1. |
27/05/2023 |
3 |
3 |
|
2. |
15/07/2023 |
3 |
3 |
|
3. |
10/11/2023 |
3 |
3 |
|
4. |
09/02/2024 |
3 |
3 |
? Members Meeting
? Nomination & Remuneration Committee Meetings
|
S. N o. |
Type of Meeting |
Date of Meeting |
Total No. of Member s Entitle to Attend |
Num ber of Mem bers Atten ded |
|
1. |
Annual General Meeting |
18-09 2023 |
1179 |
15 |
? Postal Ballot
|
S. No. |
Date of Meeting |
Strengt h of Membe rs |
No. of member s present |
|
1. |
12/04/2023 |
3 |
3 |
|
2. |
20/05/2023 |
3 |
3 |
|
3. |
03/06/2023 |
3 |
3 |
|
4. |
08/07/2023 |
2 |
2 |
|
5. |
09/08/2023 |
2 |
2 |
|
S. N o. |
Type of Meeting |
Record date |
Total No. of Members Entitle to Vote |
|
1. |
Postal Ballot |
22/12/2023 |
1196 |
? Independent Director''s Meeting
|
S. |
Date of |
Strength |
No. of |
|
No. |
Meeting |
of |
member |
|
Member |
s |
||
|
s |
present |
||
|
1. |
09/02/2024 |
2 |
2 |
? Stakeholder Relationship''s Committee Meeting
|
S. No. |
Date of Meeting |
Strength of Members |
No. of membe rs present |
|
1. |
25/09/2023 |
3 |
3 |
23. PERFORMANCE EVALUATION OF THE BOARD, COMMITTEES AND INDIVIDUAL DIRECTORS
The Company has formulated a Board Evaluation template for performance evaluation of the Independent Directors, the Board, its Committees and other individual Directors which includes criteria for performance evaluation of the Non-Executive Directors and Executive Directors.
The formal Board evaluation as mandated under the Companies Act and Listing Regulations has been carried out during the year.
24. SETTLEMENT WITH BANK OR FINANCIAL INSTITUTION:
There was no instance of one-time settlement with any Bank or Financial Institution.
25. DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT
WORKPLACE_(PREVENTION,
PROHIBITION AND REDRESSAL) ACT, 2013
The Company has in place an appropriate Policy on Prevention of Sexual Harassment of Women at Workplace in accordance with the provisions of The Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013, to prevent sexual harassment of its employees.
During the year under review, there were no cases filed pursuant to the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013.
26. DETAILS OF ESTABLISHMENT OF VIGIL MECHANISM FOR DIRECTORS AND EMPLOYEES:
The company has established a vigil mechanism for grievances redressal of director and employees of the company which will help in reporting genuine concerns or grievances of directors and employees.
As the Company does not fall under the class of companies as prescribed under Section 135 of Companies Act, 2013 and Rules made there under, therefore the provisions related to Corporate Social Responsibility is not applicable to the Company.
28. PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS UNDER SECTION 186:
Particulars of Loan given, Investments made, guarantees given and securities provided along with the purpose for which the loan or guarantee or security is proposed to be utilized by the recipient are provided in standalone financial statement.
29. PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES:
The particulars of contracts or arrangements entered into by the Company with related parties referred to in sub-section (1) of Section 188 of the Companies Act, 2013 including certain arm''s length transactions under the proviso thereto have been disclosed in Form No. AOC -2, as Annexure -II.
No Remuneration was paid to directors during the year under review.
None of the employee is in receipt of remuneration in excess of the limits prescribed under Rule 5(2) of Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 i.e. The company has not employed any employee for any post that has paid remuneration in excess of Rs. 1,02,00,000/- per annum or in excess of Rs. 8,50,000/- per month.
The Nomination & Remuneration Committee of the Board of Directors is responsible for recommending the appointment of the Directors and senior management to the Board of Directors of the Company. The Company has in place a Nomination and Remuneration Policy containing the criteria for determining qualifications, positive attributes and independence of a Director and policy relating to the remuneration for the Directors, Key Managerial Personnel and senior management personnel of the Company. The committee also postulates the methodology for effective evaluation of the performance of Individual Directors, committees of the Board and the Board as a whole which should be carried out by the Board, committee or by an independent external agency and review its implementation and compliance. The Nomination and Remuneration Policy is available on the Company''s website at https://miel.co.in.
The Company has its Risk Management Policy to identify and deal with the risks and threats that could impact the organization. Risk Management Policy is available for inspection at the Registered Office of the Company during business hours on any working day. ?
The Company has proper place and adequate internal control systems commensurate with the nature of its business, and size and complexity of its operations. Internal control systems comprising of policies and procedures are designed to ensure reliability of financial reporting, timely feedback on achievement of operational and strategic goals, compliance with policies, procedure, applicable laws and regulations, and all assets and resources are acquired economically, used efficiently and adequately protected.
35. DETAILS OF SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALS IMPACTING THE GOING CONCERN STATUS AND COMPANY''S OPERATIONS IN FUTURE:
There were no orders passed by the regulators or courts or tribunals impacting the going concern status and company''s operations in future.
The Board of Directors has from time to time framed and approved policies as required by the SEBI LODR Regulations as well as under the Companies Act, 2013. These policies will be reviewed by the Board at periodic intervals. Some of the key policies that have been adopted are as follows
Code for Disclosure of Unpublished Price Sensitive Information Code of Conduct for Insider Trading Policy on Related Party Transactions Code of Conduct for Directors and Senior Management Personnel Whistle Blower Policy
We firmly believe that employee motivation, development and engagement are key aspect of good human resource management. We provide several forums and communication channels for our employees to not only share their point of view and feedback related to our business, but also share feedback self-development and career advancement. These forums have helped us to identify and implement a number of structural changes during the year under review.
An acknowledgement with thanks is hereby conveyed to all with whose help, cooperation and hard work the Company was able to achieve the results.
By order of the Board For ASTAL LABORATORIES LIMITED CIN: L74120UP1993PLC015605
SUDHEER KARNA KANKANALA Whole Time Director DIN: 07591466
RAVIKANTI SHAILAJA Director DIN: 07629653
Mar 31, 2015
Dear Members,
The Directors have pleasure in presenting herewith the Twenty Second
Annual Report along with Audited Financial Statement of the Company for
the year ended 31st March, 2015.
FINANCIAL RESULTS
The summarized financial position of the Company for the Financial Year
ended 31st March, 2015 as compared to previous year is as under:
Amount
(Rs. in Lacs)
PARTICULARS 2014-2015 2013-2014
Total Income 33.13 34.02
Profit / (Loss) before Interest and Depreciation 6.12 12.67
Less: Finance Cost -- --
Less: Depreciation 1.09 0.92
Profit/ (Loss) before Exceptional and 5.03 11.75
Extraordinary items and Tax
Less: Current Tax 1.90 2.65
Add: Deferred Tax 15.30 0.07
Profit after Tax 18.43 9.17
Add: Balance Brought Forward from the 90.73 81.56
Previous Year
Surplus/ (Deficit) carried to Balance Sheet 109.16 90.73
DIVIDEND
With a view to conserve resources for general corporate purposes and
working capital requirements, your Director's considered it prudent not
to recommend any Dividend for the year under review.
OPERATIONS
During the year under review Total Income of the Company marginally
declined from Rs. 34.02 Lakhs to Rs. 33.13 Lakhs. Net Profit for the
year stood at Rs. 18.43 Lacs as against Rs. 9.17 Lakhs in the Previous
Year. Your Directors are making all efforts to improve performance of
the Company.
DIRECTORS
* In accordance with the provisions of the Companies Act, 2013 read
with Articles of Association of the Company, Smt. Parwati
Parasrampuria, Director of the Company retires by rotation at the
ensuing Annual General Meeting and is eligible for re- appointment.
* During the year under review Shri Shiv Saran Agarwal, resigned from
the position of Independent Directorship with effect from 31st
December, 2014. The Board places on record its deep appreciation for
the valuable contribution made by him during his tenure as Independent
Director of the Company.
* The Board has appointed Shri Gautam Lhila as an Independent Director
to fill the vacancy caused by the resignation of Shri Shiv Saran
Agarwal, subject to the approval of the Shareholders at the ensuing
Annual General Meeting.
SUBSIDIARY COMPANY/ASSOCIATE/JOINT VENTURE COMPANY
The Company has no Subsidiary , Associate or Joint Venture Company
during the year under review.
STATUTORY AUDITORS
It is proposed to appoint M/s. Chaudhary Pandiya & Co., Statutory
Auditors of the Company who hold office till the conclusion of the
ensuing Annual General Meeting and are eligible for re-appointment.
They have confirmed their eligibility that their re-appointment, if
made, would be within the prescribed limits under the Act and that they
are not disqualified for re- appointment.
The observations of Auditors in their Report read with notes to the
accounts are self- explanatory and do not call for any further
clarification or explanation.
SECRETARIAL AUDITOR
The Board has appointed M/s. Mahendra Khandelwal & Co., Practising
Company Secretaries to conduct Secretarial Audit for the Financial year
2014-15. The Secretarial Audit
Report for the Financial Year ended 31st March, 2015 is annexed
herewith as Annexure- A to this Report. As regards observation in
Secretarial Audit Report with respect to filing of Form MGT 14 for
registration of resolutions for approval of Annual Accounts and
Quarterly Results, the same has been completed. Further, in view of the
suspension of normal business operations , the Company could not afford
to employ a whole time Company Secretary and Chief Financial Officer
.However, if the operations and financial conditions
improve in future, it will make necessary appointment of Company
Secretary and Chief Financial Officer.
MEETINGS OF THE BOARD
The Board of Directors duly met 6 (Six) times respectively on 13th May,
2014, 26th May, 2014, 13th August, 2014,14th November, 2014, 31st
December, 2014 and 14th February, 2015 during the financial year. The
intervening gap between the Meetings was within the period prescribed
under the Companies Act, 2013.
BOARD EVALUATION
The Company has devised a Policy for performance evaluation of
Independent Directors, Board, Committees and other individual Directors
which includes criteria for performance evaluation of the Non-Executive
Directors and Executive Directors. On the basis of recommendations of
the Policy for Performance Evaluation of Independent Directors, Board,
Committees and other individual Directors, a process of evaluation was
followed by the Board for its own performance and that of its
Committees and individual Directors.
EXTRACT OF ANNUAL RETURN
The extract of Annual Return pursuant to the provisions of Section 92
read with Rule 12 of the Companies (Management and Administration)
Rules, 2014 in prescribed Form MGT-9 is annexed herewith as Annexure -B
to this report.
MATERIAL CHANGES AND COMMITMENTS, IF ANY, AFFECTING THE FINANCIAL
POSITION OF THE COMPANY OCCURRED BETWEEN THE END OF THE FINANCIAL YEAR
TO WHICH THESE FINANCIAL STATEMENTS RELATE AND THE DATE OF THE REPORT
No material changes and commitments affecting the financial position of
the Company occurred from the end of the Financial year 2014-15 till
the date of this Report. Further, there was no change in the nature of
business of the Company.
No significant or material order has been passed by the Regulator or
Courts or Tribunals during the Financial year.
CONTRACTS AND ARRANGEMENTS WITH RELATED PARTIES
All contracts / arrangements / transactions entered by the Company
during the Financial year with related parties were in the ordinary
course of business and on arm's length basis. Such transactions form
part of the notes to the Financial Statements provided in this Annual
Report.
PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS MADE UNDER SECTION 186
OF THE COMPANIES ACT, 2013
Loans, Guarantees and Investments covered under Section 186 of the
Companies Act, 2013 form part of the notes to the financial Statements
provided in this Annual Report.
RISK MANAGEMENT
As the Company did not pursue its main business activities during the
year no Risk Management Policy was put in place by the Board.
DISCLOSURES
Audit Committee
The Audit Committee comprises of Independent Directors namely Shri
Gautam Lhila (Chairman), Shri Manoj Kumar Poddar and Smt. Parwati
Parasrampuria as other Members. All the recommendations made by the
Audit Committee were accepted by the Board.
Vigil Mechanism
The Vigil Mechanism of the Company, which also incorporates a whistle
blower policy in terms of the Listing Agreement with the Stock
Exchange. It aims to provide an avenue for employees through this
policy to raise their concerns on any violation of legal or regulatory
requirements, suspicious fraud, misfeasance, misrepresentation of any
financial statements and reports.
Remuneration and Nomination Policy
The Board of Directors has framed a policy which lays down a framework
in relation to remuneration of Directors, Key Managerial Personnel and
Senior Management of the Company. This policy also lays down criteria
for selection and appointment of Board members. The details of this
policy are enclosed herewith as Annexure-C.
STATUTORY INFORMATION
A. PARTICULARS OF EMPLOYEES
As there are no commercial operations in the Company, none of the
employees of the Company was in receipt of remuneration in excess of
the limits prescribed under sub-rule (2) of Rule 5 of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, the
details are not required to be furnished. In view of the above
information as per sub-section (12) of Section 197 of the Companies
Act, 2013, read with sub-rule (2) of Rule 5 of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014 is
not being furnished.
B. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE
EARNINGS AND OUTGO
As the Company is not engaged in any manufacturing activity, the
details relating to Conservation of Energy, Technology Absorption being
inapplicable are not required to be given. There have been no earnings
and expenditure in foreign currency during the year under review.
C. DIRECTOR'S RESPONSIBILITY STATEMENT
In terms of Section 134(5) of the Companies Act, 2013, the Directors of
the Company state in respect of the year ended 31 st March, 2015 that
a) in the preparation of Annual Accounts, the applicable Accounting
Standards have been followed along with proper explanation relating to
material departures.
b) they have selected such Accounting policies and applied them
consistently and made judgments and estimates that are reasonable and
prudent so as to give a true and fair view of the State of Affairs of
the Company at the end of the Financial year and of the Profit of the
Company for that period.
c) they have taken proper and sufficient care for the maintenance of
adequate Accounting Records in accordance with the provisions of the
Act for safeguarding the Assets of the Company and for preventing and
detecting fraud and other irregularities.
d) they have prepared Annual Accounts on a going concern basis.
e) They have laid down internal financial controls to be followed by
the Company and that such internal controls are adequate and are
operating effectively.
DEPOSITS
The Company has neither accepted nor renewed any deposits during the
year under review.
INTERNAL FINANCIAL CONTROLS
The Company has in place adequate internal financial controls with
reference to Financial Statements. During the year, such controls were
tested and no reportable material weaknesses in the design or operation
were observed.
ACKNOWLEDGEMENTS
The Directors wish to place on record their sincere appreciation of the
co-operation received by the Company from the Company's Bankers and
other Authorities. The Directors are also thankful to the Shareholders
for abiding faith in the Company. Deep appreciation is also
acknowledged for the support and hard work put in by the employees of
the Company.
For and on behalf of the Board
Place: Kanpur (SUDHIR KUMAR PARASRAMPURIA)
Date: 14.08.2015 Chairman & Managing Director
DIN:00358982
Mar 31, 2014
Dear Members,
The Directors have pleasure in presenting herewith the Twenty First
Annual Report along with Audited Accounts of the Company for the year
ended 31st March, 2014.
FINANCIAL RESULTS
The summarized financial position of the Company for the financial year
ended 31st March, 2014 as com pared to previous year is as under:
Amount
(Rs. in Lacs)
2013-2014 2012-2013
Total Income 34.02 134.58
Profit before Depreciation & Financial Charges 12.67 16.94
Less: Depreciation 0.92 1.67
Less: Financial Charges - -
Profit before Exceptional and Extraordinary
Items and Tax 11.75 15.27
Add: Extraordinary Items - 0.36
Profit before Tax 11.75 (15.63)
Less: Tax Expenses
Current Tax 2.65 38.40
Earlier Tax - 0.41
Add: Deferred Tax 0.07 0.24
Profit after Tax 9.17 (22.94)
Add: Balance brought forward from previous year 81.55 104.49
Surplus/(Deficit) carried to Balance Sheet 90.72 81.55
DIVIDEND
With a view to conserve resources for general corporate purposes and
working capital requirements, your Directors considered it prudent not
to recommend any dividend for the year under review.
OPERATIONS
During the year under review, the Total Income of the Company declined
from Rs. 134.58 in the preceding to Rs. 34.02 Lacs in the current year.
Net Profit stood at Rs. 9.17 Lacs in the current year as against Net
Loss of Rs. 22.94 Lacs in the preceding year. Your Directors are making
constant efforts to improve the performance of the Company.
AUDITORS
The term of the present Auditors of the Company, M/s Choudhary Pandiya
& Co., Chartered Accountants, expires at the conclusion of the ensuing
Annual General Meeting and being eligible they have offered themselves
for re-appointment.
The Auditors observations read with notes to the accounts are self
explanatory and do not call for any further clarification or
explanation.
DIRECTORS
In accordance with the provisions of the Companies Act, 1956 read with
the Articles of Association of the Company Smt. Parwati Parsrampuria
Director of the Company, retires by rotation at the ensuing Annual
General Meeting and is eligible for re-appointment.
In compliance with the provisions of Section 149 of the Companies Act,
2013 your company is seeking appointment of Shri Manoj Kumar Poddar and
Shri Shiv Saran Agrawal as Independent Directors of the Company.
The Board has re-appointed Shri Sudhir Kumar Parasrampuria as Managing
Director of the Company for a further period of five years with effect
from 7th January, 2014 and the matter is placed for approval of members
at the ensuing Annual General Meeting.
STATUTORY INFORMATION
A. PARTICULARS OF EMPLOYEES
As none of the employees of the Company was in receipt of remuneration
in excess of the limits prescribed, particulars of Employees under
Section 217 (2A) of the Companies Act, 1956 read with Companies
(Particulars of Employees) Rules, 1975 as amended are not required to
be given.
B. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE
EARNINGS AND OUTGO
As the Company is not engaged in any manufacturing activity, the
details relating Conservation of Energy, Technology Absorption being
inapplicable are not required to be given. There have been no earnings
and expenditure in foreign currency during the year under review.
C. DIRECTORS'' RESPONSIBILITY STATEMENT
In terms of Section 217(2AA) of the Companies Act, 1956, the Directors
of the Company state in respect of the year ended 31st March, 2014
that:-
a) In preparation of Annual Accounts, the applicable Accounting
Standards have been followed along with proper explanation relating to
material departures.
b) They have selected such Accounting policies and applied them
consistently and made judgments and estimates that are reasonable and
prudent so as to give a true and fair view of the state of affairs of
the Company at the end of the Financial year and of the Profit of the
Company for that year.
c) They have taken proper and sufficient care for the maintenance of
adequate Accounting Records in accordance with the provisions of the
Companies Act, 1956, for safeguarding the Assets of the Company and for
preventing and detecting fraud and other irregularities.
d) They have prepared Annual Accounts on a going concern basis.
CORPORATE GOVERNANCE
The Company is committed to maintain the highest standards of Corporate
Governance and adhere to the corporate governance requirements set out
by SEBI. The Report on Corporate Governance as stipulated under Clause
49 of the Listing Agreement forms part of the Annual Report.
MANAGEMENT''S DISCUSSION AND ANALYSIS REPORT
Management''s Discussion and Analysis Report for the year under review,
as stipulated under Clause 49 of the Listing Agreement with the Stock
Exchanges in India, is presented in a separate Section forming part of
the Annual Report.
LISTING INFORMATION
The Equity Shares of the Company are presently listed at BSE Limited,
Mumbai, U.P. Stock Exchange Limited, Kanpur and Delhi Stock Exchange
Limited and the Annual Listing Fee is paid up to date.
COMPLIANCE CERTIFICATE
The Compliance certificate made by the practicing Company Secretary in
terms of the provisions of Section 383A of the Company''s Act 1956, is
attached herewith.
ACKNOWLEDGEMENTS
The Directors wish to place on record their sincere appreciation of the
co-operation received by the Company from the Company''s Bankers and
other Authorities. The Directors are also thankful to the shareholders
for abiding faith in the Company. Deep appreciation is also
acknowledged for the support and hard work put in by the employees of
the Company.
For and on behalf of the Board
Place : Kanpur (SUDHIR KUMAR PARASRAMPURIA)
Dated: 13th August, 2014 Chairman & Managing Director
DIN-00358982
Mar 31, 2013
To The Member,
The Directors hereby present the 20th Annual Report and the audited
accounts for the financial year ended 31st March, 2013.
FINANCIAL RESULTS
During the year under review Company has done a profit of Rs.
1,563,729.11 before adjustment of tax expenses. Company has done loss
of Rs. 22, 93,495.89 after deduction of tax. A debit balance of Rs.
22,93,495.89 is carried forward towards balance sheet The Board of
Directors are positive towards future growth and hope that with
effective planning & the continued co-operation of the agencies
involved and support from the management and staff, the company would
further improve its perfocmance.
DIVIDEND
Dividend is not recommended for the year ended 31-03-2013.
DIRECTORS
At present, the Board of Directors of the Company comprises of
Directors, viz. Sudhir Kuamr Parasrampuria, Smt Parwati Parasrampuria,
Shiv Saran Agarwal and Manoj Kumar Poddar. There was no change in the
composition of the Board during the period under review. Shiv Saran
Agarwal will retire by rotation at the ensuing Annual General Meeting
and eligible offers himself for re-appointment. The board recommends
for her re-appointment at the forthcoming Annual General Meeting of the
Company.
CONSERVATION OF ENEGRY. TECHNOLOGY ABSORPTION and FOREIGN EARNING
Information in accordance with the provisions of Section 217(1) (e) of
the Companies Act, 1956 read with Companies (Disclosure of Particulars
in report of Directors) Rules, 1988 regarding conservation of energy,
technology, absorption and foreign exchange earnings and outgo is given
in Annexure forming part of this report.
AUDITORS AND AUDITORS REPORT
M/s CHAUDHARY PANDIYA& CO., Chartered Accountant, KANPUR, the Auditors
of the Company retires at this meeting and has offered themselves for
re-appointment as auditors. They have furnished requisite certificate
of their eligibility for re-appointment.
The remarks in the Auditors Report are self - explanatory and
therefore, do not call for any further comments.
PERSONNEL
There is no employee in the company drawing any salary or remuneration
which attracts provisions of section 217(2a) of the companies Act, 1956
read with the Companies (Particulars of Employee) Rules, 1975.
LISTING OF SHARES- INFORMATION REGARDING STOCK EXCHANGE
The Company''s Equity Shares are listed at the Stock Exchange, Mumbai,
and The Uttar Pradesh Stock Exchange Association Ltd, Kanpur. The
Company has paid the listing fee up to the year ended 31-03-2013.
CORPORATE GOVERNENCE
A report on the Corporate Governance code is attached as a separate
annexure to this report. Necessary certification in terms of clause 49
relating to corporate governance as per the listing Agreement with
stock exchanges have been annexed and forms part of this Annual Report.
DIRECTORS'' RESPONSIBILITY STATEMENT
As required under 217 of the Companies Act, the Directors hereby
confirm that:
i. in the preparation of the Annual Accounts, the applicable accounting
standards had been followed along with proper explanation relating to
material departures.
ii. the Directors had selected such accounting policies and applied
them consistently and made judgment and estimates that are reasonable
and prudent so as to give a true and fair view of state of affairs of
the Company at the end of financial year and of the loss of the company
for that period.
iii. the Directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the
provisions of the Companies Act for safeguarding the assets of the
Company and for preventing and detecting frauds and other
irregularities.
iv. the Directors had prepared the Annual Accounts on a going concern
basis.
ACKNOWLEDGEMENT
Your Directors take this opportunity to express their sense of
appreciation of the hard work done by the staff of the company. In the
last Directors acknowledge with gratitude the confidence, which the
shareholders have reposed in them.
For And On Behalf Of the Board of Directors
Dated: 25/05/2013
Place: Kanpur (Sudhir Kumar Parasrampuria)
Chairman& Managing Director
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article